Clinical Trial Update: Vinflunine in Hormone Refractory Prostate Cancer (HRPC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for vinflunine in hormone-refractory prostate cancer has completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Vinflunine (vinflunine)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-04-04